As T1DM is featured as an autoimmune disease by activating immune cells to attack and destroy pancreatic β-cells, the immunomodulatory properties of stems cells and its potential ability of differentiation into insulin-producing cells should be considered when using stem cell therapy for T1DM treatment. The gene discussed is INS; the disease is type 1 diabetes mellitus.